Stay updated on Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial page.

Latest updates to the Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision tag v3.6.6 was added to the study record history, replacing the previous revision v3.6.5.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedA new revision entry v3.6.5 is added to the record history, replacing the previous v3.6.4. This reflects a minor update to the page's versioning.SummaryDifference0.1%

- Check51 days agoChange DetectedThe history now includes a new revision entry v3.6.4 and removes the previous revision v3.6.3 from the list.SummaryDifference0.1%

- Check72 days agoChange DetectedThe record history now shows a revision tag updated from v3.6.2 to v3.6.3, indicating a minor software update to the page.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page history shows a software release update from v3.6.0 to v3.6.2, indicating a platform version change rather than data changes to the study record.SummaryDifference0.1%

- Check94 days agoChange DetectedAdditions show that no longer looking for participants and the record revision updated to v3.6.0; Deletion removes the previous revision v3.5.5 from the history.SummaryDifference0.4%

Stay in the know with updates to Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial page.